myDawa gets KES 135 million grant from Gates Foundation to sell HIV drugs
Kenya’s e-pharmacy firm, myDAWA has secured $1.2 million USD from the Bill & Melinda Gates Foundation to increase access to PrEP (Pre-Exposure Prophylaxis) services through its model thus supporting the fight against HIV& AIDS in Kenya. This grant is an endorsement of myDawa’s ability and the crucial role it is playing in the provision of sexual and reproductive health services.
“This investment will leverage on myDawa’s well-established model to expand PrEP delivery online. Together with the University of Washington, Jomo Kenyatta University of Agriculture and Technology, Fred Hutchinson Cancer Research Center, Jhpiego, and Audere, we will develop this model, assess its feasibility, acceptability, and effectiveness in expanding the reach of PrEP. We will also generate necessary evidence and lessons learned to support policy change and further donor commitment towards this approach” said myDawa’s CEO, Tony Wood.
The Gate’s investment in myDawa aims to generate evidence on virtual PrEP service delivery. A self-care model can expand the reach of PrEP through the discreet and convenient delivery services that the e-pharmacy is well known for. Gates Foundation hopes to accelerate its goal of ensuring a decline in HIV infection worldwide and saving lives through improved interventions to prevent new infections and simplified HIV treatment. The foundation has committed more than US$3 billion in HIV grants to organizations around the world.